カテゴリ分類されていないページ

移動: 案内検索

1 件目から50 件目までの範囲内で最大 50 件の結果を表示しています。

(前の50件 | 次の50件) (20 | 50 | 100 | 250 | 500 件) を表示

  1. "Golden Suggestions": Some Tips For Rare metal Promoting, Acquiring, And A Lot More
  2. "Tillers,"in Science with the Rice Plant: Quantity A person Morphology, eds
  3. " has any bearing on her illness or the way she copes.
  4. &
  5. 's protocol. Full RNA was calculated, and 1 to 5 g were being reverse
  6. 's protocol. Total RNA was measured, and one to 5 g had been reverse
  7. (10), exactly where an progressed AGT variant is precisely labeled in vivo by
  8. (10), in which an advanced AGT variant is specially labeled in vivo by
  9. (10), where an evolved AGT variant is particularly labeled in vivo by
  10. (10), where an progressed AGT variant is specifically labeled in vivo by
  11. (10), where by an developed AGT variant is exclusively labeled in vivo by
  12. (10), wherever an advanced AGT variant is precisely labeled in vivo by
  13. (10), wherever an evolved AGT variant is specifically labeled in vivo by
  14. (10, 56). Hence, to determine much more specially the extent of sequence similarity among
  15. (10, fifty six). Hence, to ascertain a lot more exclusively the extent of sequence similarity between
  16. (10, fifty six). So, to find out additional specifically the extent of sequence similarity in between
  17. (18). Both of these techniques, coinfection with adenovirus and knockdown of U2 snRNP
  18. (18). These two methods, coinfection with adenovirus and knockdown of U2 snRNP
  19. (18). These two ways, coinfection with adenovirus and knockdown of U2 snRNP
  20. (2006) mutations map for the inside of in the channel, ruling out their
  21. (2006) mutations map for the inside of of your channel, ruling out their
  22. (2006) mutations map for the within on the channel, ruling out their
  23. (2006) mutations map into the inside of in the channel, ruling out their
  24. (2006) mutations map into the inside with the channel, ruling out their
  25. (2006) mutations map on the inside of in the channel, ruling out their
  26. (2006) mutations map on the within on the channel, ruling out their
  27. (2006) mutations map to the inside of of your channel, ruling out their
  28. (7) days and have been euthanized by CO2 asphyxiation on indications of systemic
  29. (7) times and have been euthanized by CO2 asphyxiation upon signs of systemic
  30. (7) times and have been euthanized by CO2 asphyxiation upon symptoms of systemic
  31. (Cubozoa, Carybdeidae) in die Meduse. Helgol Meeresunters 1985, 39:129-164. 115. Land MF: Animal
  32. (Cubozoa, Carybdeidae) in die Meduse. Helgol Meeresunters 1985, 39:129-164. a hundred and fifteen. Land MF: Animal
  33. (Cubozoa, Carybdeidae) in die Meduse. Helgol Meeresunters 1985, 39:129-164. one hundred fifteen. Land MF: Animal
  34. (Fig. 3f, Supplementary Fig. S4). Below these problems, PatA, also to
  35. (Fig. 3f, Supplementary Fig. S4). Less than these situations, PatA, and to
  36. (Lewen et al., 2000). Our conclusions indicate that Rit-dependent signaling is actually a
  37. (Meiklejohn et al. 2013). Together, these mutations disrupt larval metabolism, delay improvement
  38. (PDH) metabolism and had been probable cofractionated since in their association with
  39. (Perkin-Elmer LS50B; PerkinElmer Life and Analytical Sciences, Waltham, MA, USA
  40. (Warburton et al., 1986).M.W. Brown et al. / Neuropsychologia 50 (2012) 31224. Item recognition
  41. (autophagosomes), in parallel having a substantial reduce in pink puncta, confirming
  42. (eighteen). These two strategies, coinfection with adenovirus and knockdown of U2 snRNP
  43. (ii) robust neurodegeneration is present, and (iii) animals haven't nonetheless
  44. (jewelry/jewellery )
  45. (left) and inside the presence of 200 M AITC (right). (B) Summary
  46. (mutant peak is indicated by a grey arrow). The bases are
  47. (n = 15), srt mutant (n = twenty) and srt complemented strains (n = ten). Disease progression
  48. (n = fifteen), srt mutant (n = 20) and srt complemented strains (n = ten). Ailment development
  49. (n = fifteen), srt mutant (n = 20) and srt complemented strains (n = ten). Condition progression
  50. (n = fifteen), srt mutant (n = 20) and srt complemented strains (n = ten). Disease development

(前の50件 | 次の50件) (20 | 50 | 100 | 250 | 500 件) を表示